These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12118725)

  • 1. Tumour-inhibitory effects of dendritic cells administered at the site of HPV 16-induced neoplasms.
    Mendoza L; Bubeník J; Símová J; Korb J; Bieblová J; Vonka V; Indrová M; Mikysková R; Jandlová T
    Folia Biol (Praha); 2002; 48(3):114-9. PubMed ID: 12118725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth.
    Mendoza L; Indrová M; Hájková R; Reinis M; Smahel M; Vonka V; Bubeník J; Jandlová T
    Folia Biol (Praha); 2000; 46(3):91-7. PubMed ID: 10925779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Freezing and thawing of murine bone marrow-derived dendritic cells does not alter their immunophenotype and antigen presentation characteristics.
    Mendoza L; Bubeník J; Indrová M; Bieblová J; Vonka V; Símová J
    Folia Biol (Praha); 2002; 48(6):242-5. PubMed ID: 12512800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage.
    Labeur MS; Roters B; Pers B; Mehling A; Luger TA; Schwarz T; Grabbe S
    J Immunol; 1999 Jan; 162(1):168-75. PubMed ID: 9886383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
    Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
    Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours.
    Chandy AG; Nurkkala M; Josefsson A; Eriksson K
    Vaccine; 2007 Aug; 25(32):6037-46. PubMed ID: 17629599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dendritic cells present particulate E7 protein of human papillomavirus and induce strong immunity].
    Li J; Gao HQ; Zhao CL; Li LZ; Ji CY; Hou M; Plebaski M
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):932-6. PubMed ID: 15329282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
    Indrová M; Bieblová J; Jandlová T; Vonka V; Pajtasz-Piasecka E; Reinis M
    Int J Oncol; 2006 Jan; 28(1):253-9. PubMed ID: 16328003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV16-associated tumours: therapy of surgical minimal residual disease with dendritic cell-based vaccines.
    Reinis M; Indrová M; Mendoza L; Mikysková R; Bieblová J; Bubeník J; Símová J
    Int J Oncol; 2004 Oct; 25(4):1165-70. PubMed ID: 15375569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
    He T; Tang C; Xu S; Moyana T; Xiang J
    Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV 16-associated tumours: IL-12 can repair the absence of cytotoxic and proliferative responses of tumour infiltrating cells after chemotherapy.
    Indrová M; Bieblová J; Rossowska J; Kuropka P; Pajtasz-Piasecka E; Bubeník J; Reinis M
    Int J Oncol; 2009 Jan; 34(1):173-9. PubMed ID: 19082488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated differentiation of bone marrow-derived dendritic cells in atopic prone mice.
    Koike E; Takano H; Inoue K; Yanagisawa R
    Int Immunopharmacol; 2008 Dec; 8(13-14):1737-43. PubMed ID: 18775800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.
    Mikysková R; Indrová M; Símová J; Jandlová T; Bieblová J; Jinoch P; Bubeník J; Vonka V
    Int J Oncol; 2004 Jan; 24(1):161-7. PubMed ID: 14654953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local IFN-gamma therapy of HPV16-associated tumours.
    Mikysková R; Bieblová J; Símová J; Indrová M; Jandlová T; Vonka V; Smahel M; Bubeník J; Mendoza L
    Folia Biol (Praha); 2003; 49(1):26-32. PubMed ID: 12630665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours.
    Mendoza L; Bubeník J; Símová J; Jandlová T; Vonka V; Mikysková R
    Int J Oncol; 2003 Jul; 23(1):243-7. PubMed ID: 12792800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin.
    Indrová M; Bubeník J; Mikysková R; Vonka V; Smahel M; Zák R; Símová J; Bieblová J; Mendoza L; Jandlová T
    Int J Oncol; 2002 Mar; 20(3):643-6. PubMed ID: 11836582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.
    Murakami T; Tokunaga N; Waku T; Gomi S; Kagawa S; Tanaka N; Fujiwara T
    Clin Cancer Res; 2004 Jun; 10(11):3871-80. PubMed ID: 15173096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cytotoxic T lymphocytes by dendritic cells pulsed with murine leukemic cell RNA.
    Jung CW; Kwon JH; Seol JG; Park WH; Hyun JM; Kim ES; Kim ST; Lee SJ; Kim BK; Lee YY
    Am J Hematol; 2004 Mar; 75(3):121-7. PubMed ID: 14978690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.